Tag Archives for " stocks "
21 Days of Nothing: Fun Market Stats to Chew On
We really are getting a big-time summer slowdown. Some stats to chew on: -The SPX has now gone 21 trading days without a 1% move -YTD before this 21 day span, SPX moved more than 1% on nearly 1 out of 3 trading days. -During this 21 day span, SPX has moved an average of 0.3% per day -YTD before this 21 day span, SPX moved an average of 0.7% each day The VIX is now at just 11.32, levels it hasn’t seen since summer 2014’s extended downdraft, and August 2015’s spike lows. However. the VIX is actually still trading at a premium to realized SPX volatility. The premium is currently 5.5 percentage points. According to Bloomberg data, this is higher than it’s been 76% of the time over the past 5 years. Therefore, traders are to some extent already pricing in a modest volatility expansion. It does “feel” like the VIX should go up, but also keep in mind that it can stay stuck at very low levels for extended periods of time — and “should” is a dangerous word in these boring summer months. For reference, I am popping in a daily VIX chart from 2014 since so many folks are making the comparison: As you can see, the VIX traded in the 11-14 range for 4 months from April to July, had a modest spike to 17ish in August, but didn’t break 20 until October. UPDATE: Please read my latest views on the VIX here.
Continue Reading -->The Sleepy Time Market
The big bad euro bond trade is still in place with UK and Spanish 10-year yields hitting record lows. Meanwhile, the Bank of England’s Ian McCafferty said more easing will likely be required to fight the after-effects of the Brexit, and it’s steppinig up its bond purchases. That’s sending the pound lower, while the FTSE 100 is up about 0.3%. Crude oil is getting a little follow-through and is up through $43. Yesterday, oil popped on chatter that OPEC may cut output, but that is no guarantee. Remember, a lot of folks were expecting output cuts from February through June, and they never happened. So don’t get your hopes up — they could simply be trying to keep oil sellers unnerved. Coach (COH) reported better-than-expected earnings, which is a nice surprise given all the doom & gloom around luxury retail. However, Japanese cosmetics giant Shiseido cut its forecast. Troubled pharma giant Valeant (VRX) reported a sales and earnings miss, but kept its full-year forecast unchanged. The stock is up about $1.50 in early trade, indicating traders were bracing for a disaster. This is one of those odd days where there’s just not much to talk about, and the lack of movement in futures reflects that. The VIX is down again today, and I would not be surprised to see the VIX break below 11 soon. We’re basically past earnings, the Brexit, and a lot of important economic data, so it feels like the media (myself included) is reaching for stuff to talk about. Each day, I write T3 Live’s Daily Recap newsletter. I always break the day’s action into 3 easily digestible stories. And when I have trouble coming up with 3 things to talk about — like I did yesterday — you know it’s bad. I expect the same today. Yesterday, the SPX and other major indices basically grinded gears. Crude oil’s bump got oil service stocks and high-yield bonds moving hot and heavy, while health care and biotech soured. Beyond that, there wasn’t much to look at. Market volatility is still around 2-year lows, and it seems that everyone’s waiting for an excuse to do something. I’d keep the same game plan on — watch biotech, oil, high-yield, and small caps. As long as they behave decently enough, we’ll stay in good shape.
Continue Reading -->T3’s Take 3: A Record High in a Serious Snoozefest
What do you really know about prop trading? Join my friends Amber Capra and Sami Abusaad for a FREE live webinar on the exciting world of prop trading, including: The unique financial benefits of a prop trading account How to select a program that’s right for you Pitfalls you must avoid Click here for more information 1) New All-Time Highs… and Not Much Else The S&P 500 opened higher today and quickly made another record high at 2185.44. However, the index quickly settled into a tight trading range, extending the summer snoozefest. The S&P has not made a 1% move since July 8, a span of 21 trading days. This action is reminiscent of the exceedingly boring April-May stretch, which is odd considering that we’re in the middle of earnings season with plenty of central banks news and economic data surprises. Health care was weak today after drug giant Allergan (AGN) reported a revenue miss, though to be fair, the sector rose just rose 12% in a straight line off the post-Brexit lows. The S&P fell -0.1% to 2180.86 today, and the Nasdaq and Russell 2000 also posted small losses. 2) Crude Oil Bounces Back Oil’s revival off the August 3 low continued today on OPEC bullishness, with WTI crude hitting $43 for the first time since July 27. OPEC President Mohammad Al Sada said today that the current bear market in oil is “only temporary,” and that higher crude oil demand will push up prices later this year. OPEC will also meet in Algeria next month to continue discussions about a possible output ceiling, though it’s not clear that the meeting will result in any actual output changes. While the equity markets were lackluster overall, crude oil’s bounce drove solid gains in energy stocks, particularly oil service names. The Vaneck Vectors Oil Service ETF (OIH) rose 2.3% to $28.96 today. The strong oil action also boosted the high-yield bond market, which is sensitive to oil prices. 3) Not Completely Awful Is Good Enough FactSet just updated their second-quarter earnings season stats for S&P 500 companies so let’s take a look at just how awful things are: 69% of companies are beating earnings estimates (vs. 5-year average of 67%) 54% of companies are beating sales estimates (vs. 5-year average of 55%) Q2 earnings have declined -3.5%, which is less awful than the -5.5% estimated as of June 30. Health care and tech have had the highest percentage of companies reporting earnings beats This means that the same trend that’s persisted for several quarters is still in place — earnings are nothing to write home about, but they are just a little better than expected. And that’s enough to get investors to hold their noses and buy. Or maybe they’re just fooled by central banks drenching the market in monetary perfume? Tuesday’s Trading Calendar US Economics (Time Zone: EDT) 06:00 NFIB Small Business Optimism (Jul): exp. 94.5, prior 94.5 08:30 Nonfarm Productivity (2Q P): exp. 0.40%, prior -0.60% 08:30 Unit Labor Costs (2Q P): exp. 1.80%, prior 4.50% 10:00 Wholesale Inventories MoM (Jun): exp. 0.00%, prior 0.10% 10:00 Wholesale Trade Sales MoM (Jun): exp. 0.50%, prior 0.50% 10:00 IBD/TIPP Economic Optimism (Aug): exp. 47.3, prior 45.5 12:00 DOE Short-Term Crude Outlook (Aug): prior 52.15 12:00 DOE Short-Term Mogas Outlook (Aug): prior 2.28 12:00 DOE Short-Term Diesel Outlook (Aug): prior 2.71 12:00 DOE Short-Term Ht Oil Outlook (Aug): prior 2.64 12:00 DOE Short-Term NatGas Outlook (Aug): prior 10.57 Mortgage Delinquencies (2Q): prior 4.77% MBA Mortgage Foreclosures (2Q): prior 1.74% Global Economics 04:30 GBP Manufacturing Production 04:30 GBP Goods Trade Balance 23:05 AUD RBA Gov Stevens Speaks Earnings Before the Open: Bitauto Holdings (BITA) Coach Inc (COH) Incyte Corp (INCY) Norwegian Cruise Line (NCLH) Wayfair (W) After the Close: Clean Energy Fuels (CLNE) Cyberark Software (CYBR) Exone (XONE) Fossil Group (FOSL) Infinity Pharma (INFI) Solar City (SCTY) SunPower (SPWR) Twilio (TWLO) Walt Disney (DIS) Yelp Inc (YELP)
Continue Reading -->Market Analysis: There Is No Such Thing As a Perfect Rally
If you look for perfection, you’ll never be content. -Leo Tolstoy Markets are mostly in a happy mood following Friday’s NFP-driven rally. I have serious doubts as to whether the Fed’s going to raise this year, but traders are now pricing in a 47% chance of a December rate hike, up from 9% post-Brexit. I peg the odds as more like 20-25%, though admittedly, that’s based on a feeling more than anything. The yen is down on news that Japan’s Emperor Akihito publicly hinted that he will be stepping aside. German industrial production beat expectations in June (pre-Brexit data), while Visa and Market said UK consumer spending accelerated in July from June, thouhg it was Q1 numbers. France’s central bank said its economy will rise 0.3% in Q3. Economists expected a 0.2% increase. This data implies that perhaps the UK really kitchen-sinked its growth forecast, creating low expectations it can beat. As you can see in these charts of the Citi UK and EU economic surprise indexes, European economic data remains pretty solid relative to Wall Street forecasts: UK: EU: The hot bio/pharma complex may get a lift today on solid numbers from Allergan (AGN) and Horizon Pharma (HZNP). Crude oil is still on the upswing with a move over $42 this morning. OPEC’s president predicted the current dip in oil will be short-lived, and that OPEC members are in “constant deliberations” on stabilizing the market. The group will hold talks in Algiers in September. Gold is selling off as the aforementioned rate hike expectations get ratcheted up. However, bonds are pretty flat — there’s no big rush to sell. On the deal front, TIAA said it is acquiring Everbank (EVER) for $19.50/ share in cash. Everbank has been rumored to be in play for a while and just surged big-time, which explains the small premium over Friday’s $18.64 close. Sentiment is still leaning bullish, as based on the shape of the VIX curve, ISE Sentiment Index, and the Investors Intelligence Survey. The AAII survey shows that individual investors are bearish, but overall, the bulls are still quite giddy. This is why it’s important to respect price above all else. A lot of folks were declaring the market as overheated at 2100, then 2150. And today, with futures up a few points, the S&P looks like it will open at all-time highs around 2190. As far as game planning goes, I wouldn’t think too hard. Watch small caps, biotech, oil, and high-yield. When they’re moving in the right direction, it’s hard to stop the bull. I’m really zoning in on oil right now. Its ascent off the $26 February low was a major factor in the bull’s revival this year. But when it broke down from $51 to $39, the bulls didn’t skip a beat. We could be a situation where the bulls ignore oil when it goes down, and they get encouraged when oil goes back up. I hear a lot of folks complaining that the Russell 2000 hasn’t confirmed the SPX record highs, but remember: there is no such thing as a perfect rally. In almost every rally in the past few years, there’s been one type of problem or another — lousy earnings, lousy economic data, low volume, narrow leadership, etc. Good enough can be good enough. Good luck friends.
Continue Reading -->T3’s Take 3: SPX Makes Record High on Huge Jobs Report
1) Jobs Report Delivers, and Then Some! For the second month in a row, the monthly nonfarm payrolls report blew away expectations. The US economy added 255,000 jobs in July, easily smashing the 180,000 consensus. Plus, June and May’s numbers were revised higher, and average hourly earnings beat forecasts with a 0.3% gain. With two strong months in the bag, the awful May jobs report now looks like a statistical anomaly, and traders are also quickly forgetting last Friday’s weak GDP report. The market’s conclusion reaction was clear… 2) The Fed Is Gonna Hike. Really? In the aftermath of the report, investors see a higher probability of a Fed rate hike this year. Fed Funds futures now imply a 47% chance of a December rate hike, up from 37% yesterday, and just 9% post-Brexit on June 27. Plus, all the usual hawkish trades quickly fell into place today: The US dollar ripped Gold took a major hit US Treasuries fell Now as far as whether this report actually moves the Fed, I have my doubts. The Fed’s been sitting still for so long that I doubt a couple data points makes a huge difference at this point. The Brexit is also still an issue. The Bank of England made a huge downgrade to its growth forecasts, and European commercial/investment banks are doing the same, which implies a good degree of fallout. This could give the Fed another reason to hold off. But either way, the numbers had equity traders in a great mood today… 3) New Record Highs! After the numbers hit, I said I would not count out a strong rally in stocks today. I thought it would take an upward reversal in bonds to make that happen, but that was wrong. Unlike in last month’s post-NFP rally, bonds stayed down, as did gold. The S&P 500 hit a new all-time record high at 2182.87, led by a big move in bank stocks, which benefit from higher interest rates. The index rose 0.9% to close right on the highs. Regional banks were especially strong with the KRE ETF powering 3.5% higher. Small caps and transports also posted strong gains. The decliners’ column was led by the G.U.T.S complex that has dominated the action in 2016: Gold, Utilities, Treasuries, and Silver, all instruments that suffer from higher rates. Crude oil was down for most of the day on the dollar’s rise, but nearly squeezed into the green by day’s end. Monday’s Trading Calendar US Economics (Time Zone: EDT) 10:00 Labor Market Conditions Index Change (Jul): prior -1.9 Mortgage Delinquencies (2Q): prior 4.77% MBA Mortgage Foreclosures (2Q): prior 1.74% Global Economics 08:30 CAD Building Permits 21:30 AUD NAB Business Confidence 21:30 CNY CPI y/y 21:30 CNY PPI y/y Earnings Before the Open: Allergan (AGN) Dean Foods (DF) Horizon Pharma (HZNP) After the Close: Arena Pharma (ARNA) Ctrip.com (CTRP) Hertz Global (HTZ) Nuance Comm. (NUAN)
Continue Reading -->T3’s Take 3: This Bull Can’t Be Killed by Conventional Weapons
Want to Kick Your Options Trading Up a Notch? My buddy Doug Robertson is hosting a FREE options trading webinartomorrow where he’s teaching his secrets for generating major options profits in volatile markets. Click here for more information 1) This Market of Ours… The bull kept on charging ahead today, once again frustrating naysayers crying “what goes up must come down!” The S&P 500 rose 0.3% to 2163.79 today, which is not exactly a huge move. But markets looked very strong below the surface. The Russell 2000 was up 0.9%, showing pretty solid outperformance. The action in biotech was particularly impressive. Even with Biogen Idec(BIIB) down 2.7% on media outlets denying yesterday’s takeover rumors, theIBB ETF rose 1.1% to $297.92. That’s pretty surprising given that BIIB constitutes 8.7% of IBB. We also saw a major intraday rebound in crude oil prices on today’s E.I.A. inventory report, which in turn pushed up energy stocks. And on the flip side, traders took profits in safety assets like gold, silver, and utilities stocks. 2) Rumor Has It… Twitter Edition Twitter (TWTR) was once again the subject of takeover rumors, and traders are buying in even though we’ve seen this story play out all too many times. The alleged buyer is Steve Ballmer and Saudi Prince al-Waleed. Twitter call options traded at 3.2X normal volume and the stock rose 7.3% today. The recent wave of reminiscent of the nonstop rumored takeovers of BlackBerry (BBRY) back when we called it Research In Motion (RIMM). Frankly, I have a hard time believing any company’s going to pony up the $15 billion+ required to acquire Twitter, given its collapsing growth during a booming news and social media ad cycle. Plus, Twitter almost feels like it’s out of style. Ask any teens or college students what they’re hooked on, and you’ll hear Instagram and Snapchat way more than Twitter. And if you know anyone doing online marketing, ask where they’re putting their ad dollars. Many industry folks I know are throwing piles of money at Facebook (FB) because of its sophisticated targeting technology. Twitter… not so much. 3) Is Gold About to Correct? This morning, my colleague Jeff Cooper gave his views on why the Junior Gold Miners ETF (GDXJ) may be set to pull back: As the daily GDXJ below for 2016 shows, there have been 3 tests/undercuts of the 20 day line this year. Each has perpetuated a continuation in keeping with the idea of pullbacks to a rising 20 day as a Holy Grail Buy signal. When the 20 day m.a. was regained in early June, a new high followed. Ditto late July. 50 is a key level squaring out the low of the year. GDXJ broke out in the first week of February and this week is 180 degrees/days opposite early Feb. Yesterday, GDXJ gapped up setting an opening high and tailed off a tad, leaving a little Gilligan sell signal. Markets often play out in 3’s and GDXJ shows 3 tests which perpetuated 3 drives to new highs. So theoretically, a stab back below the prior swing high from July 13 at the key 50 level probably indicates a correction is on the table. P.S. T3’s Doug Robertson is hosting a free options trading webinar tomorrowafter the close. Click here for more information.
Continue Reading -->The Morning Hammer: 5 Thoughts on Today’s Market Action
Make sure you check out Doug Robertson’s options webinar, which is scheduled for Thursday after the close. Click here for more details. 1) Biotech Looks Great The SPX and NASDAQ are basically flat, but the Nasdaq Biotech ETF (IBB) is up 0.4%. That’s pretty impressive given that Biogen Idec (BIIB) is off -3.6% today as cold water was thrown on yesterday’s takeover rumors. BIIB is 7.8% of IBB, so biotech really is doing well on this shaky dayy. The S&P Biotech ETF (XBI), which is muct more diversified, giving a better view of biotech overall, is up 0.7%. 2) Crude Oil Too Strong? I’d rather see crude oil down into today’s inventory number at 10:30 a.m. ET. Oil has acted horribly and I’d rather just see an all-out collapse of expectations ahead of the data release. Economists are pricing in a -1.75 million barrely draw. We’re about to find out if that hurdle is low enough to clear. 3) Sentiment Weakening Just a Tiny Bit The VIX is flat today, but other indicators show that traders are getting a tiny bit spooked. The CBOE equity put-call ratio is still above the YTD average and the ISE Sentiment Index shows increased demand for put options. But one thing I don’t like is that the Investors Intelligence Survey has barely budged. 52.9% of newsletter writers are bullish, down just 1% from last week. That’s still within range of II’s danger zone. On balance, I’d say that traders are still pretty complacent — just not extremely so. 4) Tesla on Tap Tesla (TSLA) reports earnings today after the close, and a few options guys are chattering that Tesla options look cheap into earnings. Tesla options are pricing in a $12.84 move, which is actually small relative to some of its recent post-earnings report reactions. But I’m not so sure the options are cheap. Tesla has recently announced a boatload of news, including a capital raise, launch of Model 3 reservations, and the SolarCity (SCTY) deal. So Tesla may not have many big ‘shockers’ left to move the stock. And when you buy options into earnings, you want a big move in your direction. So tread carefully. (by the way, if you’re into options, make sure you sign up for Doug Robertson’s webinar) 5) Respect Price As of late, we’ve seen a lot of market commentators making “what goes up must come down”-type arguments against the market. Yes, we’ve come a long way since the Brexit bottom. But that’s been for good reason. Earnings season has not been as bad as expected, and economic data has generally been pretty decent. You must always remember the biggest lesson Mr. Market likes to teach — that price trends tend to last a lot longer and go further than may seem reasonable. So always respect price… even when it seems crazy. Remember, the most important question in markets is now who, what, why, or how. It’s WHEN. A great thesis means zero without equally great timing. So avoid a rush to judgement when it comes to price.
Continue Reading -->Did We Just See the Return of Volatility?
Want to Kick Your Options Trading Up a Notch? My buddy Doug Robertson is hosting a FREE options trading webinar this Thursday where he’s teaching his secrets for generating major options profits in volatile markets. Click here for more information By Michael Comeau 1) The Return of Volatility Over the past two weeks, market volatility collapsed as the S&P 500 made a succession of all-time highs within an extremely tight trading range. And in fact, the S&P hasn’t had a real down day since June 27, when it fell -1.8% in the aftermath of the June 24 Brexit vote. The zero-volatility trend felt like it started to break today as the index dropped as much as -1.1% intraday before finishing at 2156.2, down -0.7%. The Nasdaq Composite and Russell 2000 showing even bigger losses as traders cut down risk. Japan set off the selling by announcing a much smaller-than-expected increase in government spending, which sent the yen higher and global equities lower. The yen is seen as a key safety asset, and thus it tends to rise when markets are uncertain. But that wasn’t the only issue today… 2) Oil, Economic Data, Banks Crude oil gave up an early gain to slide back below the $40/barrel mark, which means it’s nearly 25% off the highs. Given that crude oil’s ascent was a major driver of equity market sentiment in the rally off the February 11 lows, a fast drop down can’t be good. We also saw some disappointing economic data, with Personal Income and PCE Deflator numbers missing expectations. This followed Friday’s lousy GDP report, which ended a pretty impressive streak of economic data beats. And finally, Germany’s Commerzbank lowered its full-year earnings forecast, with its stock dropping -8.5% intraday to a 24-year low. That put a chill under US banks. 3) So What’s Next? The pickup in volatility is a good thing, because it means fear is coming back into the market. That could be exactly what we need to reload for another leg higher following this sideways consolidation. But near-term, there’s a decent chance the market goes nowhere until Friday, when the eagerly-awaited July nonfarm payrolls report hits. Traders’ rate hike expectations have been declining since Friday’s GDP report. But strong jobs numbers could flip that around in a jiffy, which could send positive reverberations throughout global markets, which is exactly what we saw last month. Wednesday Preview US Economics (Time Zone: EDT) 07:00 MBA Mortgage Applications (7/29): prior -11.20% 08:15 ADP Employment Change (Jul): exp. 170k, prior 172k 09:45 Markit US Services PMI (Jul F): exp. 51, prior 50.9 09:45 Markit US Composite PMI (Jul F): prior 51.5 10:00 ISM Non-Manf. Composite (Jul): exp. 55.9, prior 56.5 10:30 DOE U.S. Crude Oil Inventories (7/29): exp. -2000k, prior 1671k 10:30 DOE Cushing OK Crude Inventory (7/29): exp. 275k, prior 1110k 10:30 DOE U.S. Gasoline Inventories (7/29): exp. -1000k, prior 452k 10:30 DOE U.S. Distillate Inventory (7/29): exp. -500k, prior -780k 10:30 DOE U.S. Refinery Utilization (7/29): exp. 0.00%, prior -0.80% 10:30 DOE Crude Oil Implied Demand (7/29): prior 16713 10:30 DOE Gasoline Implied Demand (7/29): prior 10250.9 10:30 DOE Distillate Implied Demand (7/29): prior 5122.4 Global Economics 04:30 GBP Services PMI 21:30 AUD Retail Sales m/m Earnings Before the Open: 3D Systems (DDD) Charles River Laboratories (CRL) Humana (HUM) After the Close: Albemarle Corp (ALB) Allstate Corp (ALL) Continental Resources (CLR) J2 Global (JCOM) Oasis Petroleum (OAS) Tesla Motors (TSLA)
Continue Reading -->Earnings Season Stinks… Just Not As Much As We Thought
We came into earnings season with remarkably low expectations. But it turns out things don’t stink that much. FactSet just updated their earnings season stats, and as of Friday, things stink — just not as much as they were expected to. At the end of Q2, traders expected a revenue decline of -0.8%. And as of last week, actual results have dragged that number up to +0.1%. 57% of companies have beaten revenue forecasts, which is slightly above the 55% 5-year average. Consumer discretionary (namely AMZN), Tech (think AAPL), Health Care, and Financials have been leading the way The earnings side is looking decent too. Q2 is showing a -3.7% earnings decline. Now that’s pretty bad on its head, but at the end of Q2, analysts expected a -5.5% decline. The conclusion: once again, earnings season stinks… just not as much as we thought. And remember, these numbers don’t reflect today’s solid earnings reports from Pfizer (PFE), CVS (CVS), and others. This is another reason the market’s falling apart. Everyone’s been bracing for disaster and we’re clearly not getting it. And of course, it helps that economic data has been generally decent. Disclosure: Position in AAPL
Continue Reading -->The Morning Hammer: Weak Oil Means Nothing to This Bull
I’ve been out since last Thursday to get my eyeballs upgraded but not much has changed. When I’m not working, I make a point of not looking at the market or reading anything related to it. But I didn’t miss a thing. Crude oil is still deteriorating, yet SPX cracked yet another all-time high. The index has been consolidating in a remarkably tight range between 2160ish and 2180ish. I’ve been predicting that the market would head into a snoozefest like the one in April-May, and we’ve been getting it thus far. Futures are down slightly on weak earnings from Germany’s Commerzbank and a smaller-than-expected spending package from Japan which is sending the yen up. As you probably know, a strong yen means risk-off, though US markets have been yawning at everything including the kitchen sink. Sentiment is cooling off just a smidge. The ISE Sentimenmt Index fell to 72 yesterday and hasn’t been over 100 since July 18. That means call option demand is waning a bit, a good sign for the bulls because it means we’re still digesting and doubt is building. Pfizer (PFE) beat analysts’ expectations but is trading off slightly. We’re also seeing good numbers out of CVS (CVS), Procter & Gamble (PG), and Shire Plc. Watch closely to see how the pharma/biotech complex reacts. We’ve got some big economic data points on tap today, with Personal Income/Spending and the PCE Deflator (the Fed’s preferred inflation measure) on the way. As of late, US economic data has been generally strong relative to expectations, though Friday’s GDP report was lousy. Check out the chart below of the Citi US Economic Surprise Index: I added the UK index just for the fun of it so you can see that the Brexit impact hasn’t been that bad so far: Now, what’s interesting is that the weak GDP numbers turned traders a little more dovish. Fed Funds futures now imply a 36% probability of a December rate hike, down from 48% last week. Strong economic data this morning could flip it back. As I’ve been emphasizing, perceptions of the Fed’s forward path are EXTREMELY volatile. Remember, after the Brexit, traders priced in a 9% chance of a December rate hike. And in less than a month, that number was up to 50%. So if you’re trading bonds, golds, forex, or anything else that’s rate-sensitive, you may be in for quite a ride. Good luck friends.
Continue Reading -->